Sort
16,300 grants matching “fatty liver disease”
Effects of recombinant human leptin in nonalcoholic fatty liver disease (NAFLD)
$338,213Elif Arioglu Oral · University Of Michigan At Ann Arbor · R01 · FY2012 · DK
Effects of recombinant human leptin in nonalcoholic fatty liver disease (NAFLD)
$338,213Elif Arioglu Oral · University Of Michigan At Ann Arbor · R01 · FY2014 · DK
Effects of recombinant human leptin in nonalcoholic fatty liver disease (NAFLD)
$338,213Elif Arioglu Oral · University Of Michigan At Ann Arbor · R01 · FY2015 · DK
Research Project 2: PFAS and Liver Health in Latino Youth: A Longitudinal Multi-Omics Study
$338,149Vaia Lida Chatzi · University Of Southern California · P42 · FY2025 · ES
Metabolic control of hepatocellular carcinoma by PGC1alpha
$338,117Geoffrey D Girnun · University Of Maryland Baltimore · R01 · FY2012 · CA
Role of NCOA5 in hepatic steatosis and hepatocarcinogenesis
$338,033Hua Xiao · Michigan State University · R01 · FY2018 · CA
Regulation of 15N Urea Isotopomers Production
$337,924Itzhak Nissim · Children'S Hosp Of Philadelphia · R01 · FY2012 · DK
Regulation of 15N Urea Isotopomers Production
$337,924Itzhak Nissim · Children'S Hosp Of Philadelphia · R01 · FY2011 · DK
PPAR Delta Functions in Liver
$337,886Chih-Hao Lee · Harvard School Of Public Health · R01 · FY2012 · DK
Regulation of cholesterol catabolism by bile acids
$337,818Jongsook Kim Kemper · University Of Illinois At Urbana-Champaign · R01 · FY2014 · DK
Mechanisms of obesity-induced hepatocarcinogenesis
$337,795Fung-Lung Chung · Georgetown University · R01 · FY2018 · CA
Cell free Hemoglobin, lipid oxidation and Nitric oxide in Sickle Cell Disease
$337,769Neil Hogg · Medical College Of Wisconsin · U54 · FY2008 · HL
Harnessing mechanical signals to control mesenchymal stem cell fate
$337,722Clinton T Rubin · State University New York Stony Brook · R01 · FY2014 · EB
PROJECT 4: Targeting Methionine Adenosyltransferases in Liver Metastasis
$337,611Shelly Chi-Loo Lu · Cedars-Sinai Medical Center · P01 · FY2021 · CA
Dietary factors in the pathogenesis of steatohepatitis
$337,577Jacquelyn J. Maher · University Of California, San Francisco · R01 · FY2007 · DK
MOLECULAR REGULATION OF APOPROTEIN B DEGRADATION
$337,552Mount Sinai School Of Medicine Of Nyu · R01 · FY2001 · HL
The role of TCTP in regulating adiponectin signaling
$337,546Lily Q. Dong · University Of Texas Hlth Science Center · R01 · FY2015 · DK
Targeting Uric Acid as a Therapeutic for NASH
$337,544Nicholas Khoo · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · DK
Complement and ethanol-induced liver injury.
$337,544Laura E. Nagy · Cleveland Clinic Lerner Com-Cwru · R01 · FY2009 · AA
Complement and ethanol-induced liver injury.
$337,544Laura E. Nagy · Cleveland Clinic Lerner Com-Cwru · R01 · FY2008 · AA
Complement and ethanol-induced liver injury.
$337,544Laura E. Nagy · Cleveland Clinic Lerner Com-Cwru · R01 · FY2007 · AA
Fatty Liver Preventive Effects and High Dose Hepatotoxicity of Tea Polyphenols
$337,528Joshua D Lambert · Pennsylvania State University, The · R01 · FY2013 · AT
PCBs worsen obesity/metabolic syndrome through 'toxic metabolic endotoxemia'
$337,500Matthew C Cave · University Of Louisville · R01 · FY2016 · ES
PCBs worsen obesity/metabolic syndrome through 'toxic metabolic endotoxemia'
$337,500Matthew C Cave · University Of Louisville · R01 · FY2015 · ES
Hypo-Lipidemic Actions of Creosote Bush-Derived NDGA
$337,408Salman Azhar · Palo Alto Veterans Instit For Research · R01 · FY2013 · HL